Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 1
Results: 11
Correction to: Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Infammation and Pain Following Ocular Surgery.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 99, doi. 10.1007/s40261-020-00990-8
- By:
- Publication type:
- Article
Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 19, doi. 10.1007/s40261-020-00989-1
- By:
- Publication type:
- Article
Single-Dose Pharmacokinetics, Pharmacodynamics and Immunogenicity, and Multiple-Dose Immunogenicity of INTP5 (Pegfilgrastim Biosimilar) Versus Reference Pegfilgrastim in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 29, doi. 10.1007/s40261-020-00987-3
- By:
- Publication type:
- Article
Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 89, doi. 10.1007/s40261-020-00986-4
- By:
- Publication type:
- Article
CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Targeted Use of Prednisolone with Intravenous Immunoglobulin for Kawasaki Disease.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 77, doi. 10.1007/s40261-020-00984-6
- By:
- Publication type:
- Article
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 43, doi. 10.1007/s40261-020-00982-8
- By:
- Publication type:
- Article
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 65, doi. 10.1007/s40261-020-00981-9
- By:
- Publication type:
- Article
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 53, doi. 10.1007/s40261-020-00979-3
- By:
- Publication type:
- Article
Preferential Antiseizure Medications in Pediatric Patients with Convulsive Status Epilepticus: A Systematic Review and Network Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 1, doi. 10.1007/s40261-020-00975-7
- By:
- Publication type:
- Article